New Study Links Ozempic To Vision Loss, Confirms Harvard Research – Era of Light

By Tyler Durden | Source Another study has been published suggesting that patients taking semaglutide—the active ingredient in Novo Nordisk's blockbuster drug Ozempic—may face a higher risk of developing a rare eye condition that can lead to blindness. "The glucagon-like peptide 1 receptor..